Inventor · disambiguated record
Birgit Maria Reipert
Also filed as: REIPERT BIRGIT · REIPERT BIRGIT MARIA
13 granted patents·7 pending applications·42 citations·filing 2008–2022
89Inventor score
Top patents by PatentIndex Score
20 records- 0184US7968293B2IVIG modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's diseaseBAXTER INT·Filed 2008·Granted Jun 28, 2011·10 cites·13 claims
- 0283US9512198B2FVIII peptides for immune tolerance induction and immunodiagnosticsBAXALTA INC·Filed 2015·Granted Dec 6, 2016·5 cites·20 claims
- 0381US8962912B2Transgenic non-human animals expressing human blood clotting factors and uses thereofSASGARY MARIA·Filed 2011·Granted Feb 24, 2015·11 cites·11 claims
- 0479US8216793B2Detection of antibody that binds to water soluble polymer-modified polypeptidesLUBICH CHRISTIAN·Filed 2010·Granted Jul 10, 2012·5 cites·13 claims
- 0575US10494418B2IgG stimulated remyelination of peripheral nervesBAXALTA INC·Filed 2017·Granted Dec 3, 2019·1 cites·64 claims
- 0675US8969524B2FVIII peptides for immune tolerance induction and immunodiagnosticsSTEINITZ KATHARINA NORA·Filed 2011·Granted Mar 3, 2015·5 cites·20 claims
- 0773US2020216518A1IgG STIMULATED REMYELINATION OF PERIPHERAL NERVESBAXALTA INC·Filed 2019·Application pending·0 cites
- 0872US2021300997A1IgG STIMULATED REMYELINATION OF PERIPHERAL NERVESTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 0970US9834593B2IgG stimulated remyelination of peripheral nervesBAXALTA INC·Filed 2015·Granted Dec 5, 2017·1 cites·35 claims
- 1066US12071468B2Purification of Factor VIII subspeciesTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Aug 27, 2024·0 cites·16 claims
- 1165US8986670B2IgG stimulated remyelination of peripheral nervesHEINRICH HEINE UNIVERSITÄT·Filed 2013·Granted Mar 24, 2015·1 cites·13 claims
- 1263US8852874B2Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitroOLAS KATARZYNA·Filed 2009·Granted Oct 7, 2014·3 cites·20 claims
- 1358US11299533B2Purification of factor VIII subspeciesTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 12, 2022·0 cites·9 claims
- 1457US11921117B2Characterization of subvisible particles using a particle analyzerBAXALTA INC·Filed 2019·Granted Mar 5, 2024·0 cites·19 claims
- 1556US2009235369A1Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses ThereofBAXTER HEALTHCARE SA·Filed 2008·Application pending·0 cites
- 1652US2020405883A1Method of treatment with viral-based gene therapyBAXALTA INC·Filed 2020·Application pending·0 cites
- 1748US10274500B2Characterization of subvisible particles using a particle analyzerBAXALTA INC·Filed 2013·Granted Apr 30, 2019·0 cites·35 claims
- 1848US2017267743A1Fviii peptides for immune tolerance induction and immunodiagnosticsBAXALTA INC·Filed 2016·Application pending·0 cites
- 1948US2012309021A1Detection of antibody that binds to water soluble polymer-modified polypeptidesLUBICH CHRISTIAN·Filed 2012·Application pending·0 cites
- 2042US2011177094A1Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's diseaseBAXTER INT·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →